UPDATE: Prima BioMed Raises A$1.55M Through Private Placement to Nyenburgh Investment Partners @A$0.05/Share

By: via Benzinga
Prima BioMed Ltd (NASDAQ: PBMD) ("Prima" or the "Company"), a leading immuno-oncology company, announces that it has raised €1M (approx. ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.